Performance of the imPulse device for the detection of atrial fibrillation in hospital settings

McDonagh, S. T.J., Rhodes, S., Warren, F. C., Keenan, S., Pentecost, C., Keeling, P., James, M., Taylor, R. S. and Clark, C. E. (2022) Performance of the imPulse device for the detection of atrial fibrillation in hospital settings. Cardiovascular Digital Health Journal, 3(4), pp. 171-178. (doi: 10.1016/j.cvdhj.2022.05.002)

[img] Text
277358.pdf - Published Version
Available under License Creative Commons Attribution.

361kB

Abstract

Background: Atrial fibrillation (AF) increases thromboembolism and stroke risk; this can be reduced by oral anticoagulation, but only if AF is detected. A portable, point-of-care device, capable of accurately detecting and identifying AF, could reduce workload and diagnostic delay by minimizing need for follow-up 12-lead electrocardiogram (ECGs). Objective: To assess the diagnostic performance of the Plessey imPulse lead I ECG device compared with a 12-lead ECG in detecting AF. Methods: Cross-sectional diagnostic accuracy study. Participants underwent simultaneous 12-lead ECG and imPulse device recordings. The imPulse device reports AF to be “probable,” “possible,” “unlikely,” or “uncontrolled AF unlikely.” imPulse and ECG reference results were cross-tabulated; sensitivity, specificity, positive/negative predictive values, and positive/negative likelihood ratios with 95% confidence interval (CI) were estimated based on different imPulse device report categorizations and heart rate subgroups. Results: A total of 217 participants were recruited (mean age 70.2 [standard deviation 12.7]), 56% male, 57% outpatients, 43% inpatients) and 199 were included in analyses. AF was diagnosed on ECG for 41 of 199 (20.6%) participants and reported by imPulse as possible, probable, or uncontrolled AF unlikely present for 49 of 199 (24.6%). Sensitivity and specificity for imPulse detection of possible, probable, or uncontrolled AF unlikely vs unlikely, compared with ECG, were 80.5% (95% CI, 65.1%–91.2%) and 89.9% (84.1%–94.1%), respectively. When probable or uncontrolled AF unlikely were compared vs possible or unlikely AF, sensitivity and specificity were 63.4% (46.9%–77.9%) and 98.1% (94.6%–99.6%), respectively. Conclusion: The imPulse device has moderate sensitivity and good specificity compared with ECG AF detection in a hospital setting.

Item Type:Articles
Additional Information:This study was funded by Plessey Semiconductors Ltd.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Taylor, Professor Rod
Authors: McDonagh, S. T.J., Rhodes, S., Warren, F. C., Keenan, S., Pentecost, C., Keeling, P., James, M., Taylor, R. S., and Clark, C. E.
College/School:College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > MRC/CSO SPHSU
Journal Name:Cardiovascular Digital Health Journal
Publisher:Elsevier
ISSN:2666-6936
ISSN (Online):2666-6936
Published Online:26 May 2022
Copyright Holders:Copyright © 2022 The Authors
First Published:First published in Cardiovascular Digital Health Journal 3(4):171-178
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record